These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

32 related articles for article (PubMed ID: 16160630)

  • 1. Management of treatment-resistant generalized anxiety disorder.
    Ansara ED
    Ment Health Clin; 2020 Nov; 10(6):326-334. PubMed ID: 33224690
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Aligning the many definitions of treatment resistance in anxiety disorders: A systematic review.
    Bokma WA; Wetzer GAAM; Gehrels JB; Penninx BWJH; Batelaan NM; van Balkom ALJM
    Depress Anxiety; 2019 Sep; 36(9):801-812. PubMed ID: 31231925
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pharmacotherapy for generalized anxiety disorder in adult and pediatric patients: an evidence-based treatment review.
    Strawn JR; Geracioti L; Rajdev N; Clemenza K; Levine A
    Expert Opin Pharmacother; 2018 Jul; 19(10):1057-1070. PubMed ID: 30056792
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Canadian clinical practice guidelines for the management of anxiety, posttraumatic stress and obsessive-compulsive disorders.
    Katzman MA; Bleau P; Blier P; Chokka P; Kjernisted K; Van Ameringen M; ; Antony MM; Bouchard S; Brunet A; Flament M; Grigoriadis S; Mendlowitz S; O'Connor K; Rabheru K; Richter PM; Robichaud M; Walker JR
    BMC Psychiatry; 2014; 14 Suppl 1(Suppl 1):S1. PubMed ID: 25081580
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Role of atypical antipsychotics in the treatment of generalized anxiety disorder.
    Hershenberg R; Gros DF; Brawman-Mintzer O
    CNS Drugs; 2014 Jun; 28(6):519-33. PubMed ID: 24794100
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Treatment of generalized anxiety disorder: a comprehensive review of the literature for psychopharmacologic alternatives to newer antidepressants and benzodiazepines.
    Huh J; Goebert D; Takeshita J; Lu BY; Kang M
    Prim Care Companion CNS Disord; 2011; 13(2):. PubMed ID: 21977338
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Treatment strategies for dosing the second generation antipsychotics.
    Schwartz TL; Stahl SM
    CNS Neurosci Ther; 2011 Apr; 17(2):110-7. PubMed ID: 21401911
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Contextual conditioning in rats as an animal model for generalized anxiety disorder.
    Luyten L; Vansteenwegen D; van Kuyck K; Gabriëls L; Nuttin B
    Cogn Affect Behav Neurosci; 2011 Jun; 11(2):228-44. PubMed ID: 21302154
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Current considerations in the treatment of generalized anxiety disorder.
    Katzman MA
    CNS Drugs; 2009; 23(2):103-20. PubMed ID: 19173371
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Ziprasidone for schizophrenia and bipolar disorder: a review of the clinical trials.
    Greenberg WM; Citrome L
    CNS Drug Rev; 2007; 13(2):137-77. PubMed ID: 17627670
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Use of ziprasidone in parkinsonian patients with psychosis.
    Gómez-Esteban JC; Zarranz JJ; Velasco F; Lezcano E; Lachen MC; Rouco I; Barcena J; Boyero S; Ciordia R; Allue I
    Clin Neuropharmacol; 2005; 28(3):111-4. PubMed ID: 15965308
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Strategies for successful clinical management of schizophrenia with ziprasidone.
    Fagiolini A; Cañas F; Gallhofer B; Larmo I; Levy P; Montes JM; Papageorgiou G; Zink M; Rossi A
    Expert Opin Pharmacother; 2010 Sep; 11(13):2199-220. PubMed ID: 20658947
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Focus on ziprasidone.
    Green B
    Curr Med Res Opin; 2001; 17(2):146-50. PubMed ID: 11759185
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Open-label pilot study of ziprasidone for refractory generalized anxiety disorder.
    Snyderman SH; Rynn MA; Rickels K
    J Clin Psychopharmacol; 2005 Oct; 25(5):497-9. PubMed ID: 16160630
    [No Abstract]   [Full Text] [Related]  

  • 15. Ziprasidone in adolescents with autism: an open-label pilot study.
    Malone RP; Delaney MA; Hyman SB; Cater JR
    J Child Adolesc Psychopharmacol; 2007 Dec; 17(6):779-90. PubMed ID: 18315450
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Sudden death in a patient with Tourette syndrome during a clinical trial of ziprasidone.
    Scahill L; Blair J; Leckman JF; Martin A
    J Psychopharmacol; 2005 Mar; 19(2):205-6. PubMed ID: 15728441
    [No Abstract]   [Full Text] [Related]  

  • 17.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 18.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 19.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 2.